Drug Repurposing

Experts flag shingles vaccine, sildenafil and riluzole as leading Alzheimer’s repurposing candidates

February 18, 2026 由 AI 报道 AI 生成的图像 事实核查

A University of Exeter-led study funded by Alzheimer’s Society has identified three already-approved medicines—the shingles vaccine Zostavax, sildenafil (Viagra) and riluzole—as top “priority” candidates to be tested in clinical trials for Alzheimer’s disease, after a structured review of 80 existing drugs by an international expert panel.